N@N

PSDV, THLD, AWI, PMC, NMM, JBT Are Seasonally Ripe To Go Down In the Next Five Weeks

January 16, 2017 / M2 PRESSWIRE / BUYINS.NET / www.buyins.net is monitoring the Seasonality of pSivida Corp. (NASDAQ:PSDV), Threshold Pharmaceuticals Inc. (NASDAQ:THLD), Armstrong World Industries Inc. (NYSE:AWI), PharMerica Corporation (NYSE:PMC), Navios Maritime Partners L.P. (NYSE:NMM), John Bean Technologies Corporation (NYSE:JBT) and each have a high seasonal probability to go Down in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. buyins.net is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:

The following stocks are expected to go Down:

  Symbol  Company                          Expected Return  Odds                 By The Following Date
  PSDV    pSivida Corp.                    -5.83%           87.50% (7 of 8)      Friday, January 27th 2017
  THLD    Threshold Pharmaceuticals Inc.   -7.99%           90.91% (10 of 11)    Wednesday, January 25th 2017
  AWI     Armstrong World Industries Inc.  -4.11%           90.00% (9 of 10)     Friday, January 20th 2017
  PMC     PharMerica Corporation           -5.30%           88.89% (8 of 9)      Friday, January 27th 2017
  NMM     Navios Maritime Partners L.P.    -4.48%           100.00% (9 of 9)     Thursday, February 16th 2017
  JBT     John Bean Technologies Corporation  -4.51%           87.50% (7 of 8)      Monday, January 30th 2017

pSivida Corp. (NASDAQ:PSDV) - pSivida Corp. develops sustained-release drug-delivery products for the treatment of chronic eye diseases in the United States and the United Kingdom. It offers ILUVIEN, an injectable, sustained-release micro-insert for use in treating vision impairment associated with diabetic macular edema; and Retisert for the treatment of posterior segment uveitis. The company is also developing Medidur, an injectable, sustained-release micro-insert, which is in Phase III clinical trials for the treatment of chronic non-infectious uveitis affecting the posterior segment of the eye. Its pre-clinical development program focuses on developing products using its core platform technologies, Durasert and Tethadur, to deliver drugs and biologics to treat wet and dry age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. The company has strategic collaborations with Alimera Sciences, Inc.; Pfizer, Inc.; Bausch & Lomb Incorporated; and Enigma Therapeutics Limited. pSivida Corp. was founded in 1987 and is headquartered in Watertown, Massachusetts..

Threshold Pharmaceuticals Inc. (NASDAQ:THLD) - Threshold Pharmaceuticals, Inc. discovers and develops therapeutic agents that target tumor cells for the treatment of cancer patients in the United States. Its lead investigational small molecule is evofosfamide, which is in two Phase III clinical trials for the treatment of soft tissue sarcoma indication and advanced pancreatic cancer; Phase II clinical trials for treating non-squamous non-small cell lung cancer; Phase II clinical trials for advanced melanoma; and Phase I/II clinical trials for multiple myeloma. The company is also involved in the study of evofosfamide in investigator sponsored trials, including Phase I/II clinical trials for glioblastoma; Phase I clinical trials for advanced renal cell carcinoma, gastrointestinal stromal tumors, and pancreatic neuroendocrine tumors; Phase II clinical trials for glioblastoma and pancreatic neuroendocrine tumors; Phase I clinical trials for advanced solid tumors; and Phase I/II clinical trials for advanced kidney cancer or liver cancer. In addition, it engages in developing Tarloxotinib, a hypoxia-activated EGFR tyrosine kinase inhibitor, which is in two Phase II clinical trials for patients with advanced non-squamous non-small cell lung cancer, as well as patients with squamous cell carcinomas of the head, neck, or skin; and [18F]-HX4, an investigational PET imaging agent for hypoxia. The company has a license agreement with Merck KGaA to co-develop and commercialize evofosfamide; license agreement with Auckland UniServices Ltd. for the development program based on Tarloxotinib; and license agreement with Eleison Pharmaceuticals, Inc. for the manufacture, development, and commercialization of glufosfamide for the treatment of cancer in humans and animals, as well as other uses. It also has a collaboration with the National Cancer Institute to study TH-3424, a drug candidate for the treatment of cancer. Threshold Pharmaceuticals, Inc. was founded in 2001 and is headquartered in South San Francisco, California..

Armstrong World Industries Inc. (NYSE:AWI) - Armstrong World Industries, Inc. designs, manufactures, and sells flooring products and ceiling systems for use primarily in the construction and renovation of residential, commercial, and institutional buildings worldwide. The company s Building Products segment produces suspended mineral fibers, soft fibers, and metal ceiling systems for use in commercial, institutional, and residential settings, as well as complementary ceiling products; and sells suspension system products. This segment sells its commercial ceiling materials and accessories to resale distributors and ceiling system contractors; and residential ceiling products to wholesalers and retailers, including large home centers. Its Resilient Flooring segment manufactures vinyl sheet and tile flooring, as well as sources and sells laminate flooring products, vinyl tile products, vinyl sheet products, linoleum products, adhesives, and installation and maintenance materials and accessories. This segment sells its products to wholesale flooring distributors, large home centers, retailers, and contractors, as well as to the manufactured homes industry. The company s Wood Flooring segment offers pre-finished solid and engineered wood floors, and related accessories for use in new residential construction and renovation with various commercial applications in stores, restaurants, and offices. This segment sells its products to independent wholesale flooring distributors, large home centers, retailers, and flooring contractors. The company was incorporated in 1891 and is headquartered in Lancaster, Pennsylvania..

PharMerica Corporation (NYSE:PMC) - PharMerica Corporation operates as an institutional pharmacy services company in the United States. The company offers services to healthcare facilities; pharmacy management services to hospitals; specialty infusion services to patients outside hospitals; and oncology pharmacy services. It purchases, repackages, and dispenses prescription and non-prescription pharmaceuticals in accordance with physician orders and delivers such medication to healthcare facilities for administration to individual patients and residents. The company also provides hospital pharmacy management services, including hospital pharmacy operations, regulatory and financial management services, and clinical pharmacy programs; and consultant pharmacist services and medical records services. It operates 94 institutional, 17 specialty infusion, and 5 specialty oncology pharmacies in 45 states. The company serves institutional healthcare providers, such as skilled nursing facilities, nursing centers, assisted living facilities, hospitals, individuals receiving in-home care, and other long-term alternative care providers. PharMerica Corporation was founded in 2006 and is headquartered in Louisville, Kentucky..

Navios Maritime Partners L.P. (NYSE:NMM) - Navios Maritime Partners L.P. owns and operates dry cargo vessels in Europe, Asia, North America, and Australia. It provides seaborne transportation services for a range of dry cargo commodities that include iron ore, coal, grain, and fertilizers, as well as charters its vessels under medium to long-term charters. The company s fleet comprises 12 Panamax vessels, 8 Capesize vessels, 3 Ultra-Handymax vessels, and 8 container vessels. Navios GP L.L.C. serves as the general partner of Navios Maritime Partners L.P. The company was founded in 2007 and is based in Monaco..

John Bean Technologies Corporation (NYSE:JBT) - John Bean Technologies Corporation designs, manufactures, tests, and services products and systems for food and beverage, and air transportation industries. It operates through JBT FoodTech and JBT AeroTech segments. The company provides protein product solutions that include mixing/grinding, injecting, marinating, tumbling, portioning, coating, frying, and freezing for poultry, beef, pork, and seafood, as well as ready-to-eat meals, fruits, vegetables, dairy, and bakery products; and liquid food solutions for filling, closing and sterilization of fruits, vegetables, soups, sauces, dairy, and pet food products, as well as to extract, concentrate, and aseptically process citrus, tomato and other fruits, vegetables, and juices. It also offers automatic guided vehicles for use in material handling in the manufacturing and warehouse industries; clipping systems, including table, semi-automatic, and automatic clippers, as well as net and clip, bag and clip, and hanging systems; processing machines, which include fine cutters/emulsifiers and bowl choppers; and consumables, such as clips, loops, labeling systems, and string and cord solutions. In addition, the company provides mobile air transportation equipment, such as commercial and military cargo loading, aircraft deicing, aircraft towing, and ground aircraft power and cooling systems; and airport gate equipment for passenger boarding, as well as maintenance services for airport equipment, systems, and facilities. Further, it offers air transportation solutions to airport authorities, airlines, airfreight, and ground handling companies, as well as military and defense contractors. The company provides its products and solutions through direct sales force, independent distributors, and sales representatives in the United States and internationally. John Bean Technologies Corporation is headquartered in Chicago, Illinois..

About BUYINS.NET

BUYINS.NET, http://www.buyins.net, monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market-maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS Friction Factor - Market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements" Naked Shorts (RegSho) - Tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO

INVESTMENTS & TRADING Earnings - Predicts probability, price move and length of move before and after all US stock earnings reports Seasonality - Predicts probability, price move and length of move based on exact time of year for all US stocks Group Correlation - Tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups SqueezeTrigger - Massive database that tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock. Valuation - Tracks all known valuation models and applies them. GATS - Tracks and quantifies known trading strategies by backtesting, optimizing and running genetic algorithms and neural networks to ascertain best trading strategies. PatternScan - Automates tracking of every technical pattern and predicts next move in stocks. Insider - Tracks insiders trading records and determines trading performance. Trades by higher-level insiders are generally more predictive than trades by lower level insiders Events - Tracks patterns directly correlated to specific events.

SqueezeTrigger is a registered trademark, Reg. No. 3,120,641

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. [symbol] has not approved the statements made in this release. Please read our report and visit our web site, http://www.buyins.net, for complete risks and disclosures.

Contact: BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net http://www.buyins.net

Contributing Sources

---